Innovative Approaches to the Management of Surgical Site infection with Secretome from Placental Wharton Jelly Stem Cell (SC-PWJSC)

Surgical site infection is one of the postoperative complications that occur within 30 days after surgery. Surgical site infection is one of the causes of increased postoperative morbidity and mortality, with the probability of successful wound healing being less than 50% with conventional methods. One of the innovative methods of managing surgical site infections is using Secretome From Placental Wharton Jelly Stem Cell (SC-PWJSC). This report discusses the case of a 57-year-old man who experienced surgical site infection after a lower leg amputation. The patient was given treatment using Secretome From Placental Wharton Jelly Stem Cell (SC-PWJSC) by injection once on the first day, and topically used twice a day. During 28 days of treatment, the wound healing was perfect without any side effects resulting from this intervention.